Approximately 400,000 people in the United States are living
with MS. Worldwide, more than 2.1 million people are afflicted
with the disease, many with different symptoms and levels of
severity. The disease is unpredictable. While treatments and
medication currently on the market can help slow down the
attacks, there is no cure. But the cure for MS just might be
sitting right in southeastern Wisconsin's backyard. Endece LLC,
a Mequon-based drug discovery company, recently formed Endece
Neural, a subsidiary company focused on neurological drug
development. More specifically, Endece Neural is pursing the
development of a drug that could help repair and even reverse
the damage caused by MS. Endece's work is getting some attention
in the world of MS research. "We're very excited about the
Endece compounds," said Jay Tung, president of drug discovery at
the Myelin Repair Foundation in San Francisco. Endece hopes to
collect enough data so the U.S. Food and Drug Administration
will accelerate clinical testing enough